AMGEN Inc
NASDAQ: AMGN
$293.54
-$4.24 (-1.4%)
Closing Price on February 7, 2025
AMGN Articles
The three major U.S. stock indexes opened lower this morning and remained in negative territory all day. The decline is down to weak earnings from many U.S. firms reporting results today. In Europe,...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research notes this Tuesday. AMC Networks Inc. (NASDAQ: AMCX) cut to Neutral at JPMorgan. Amgen Inc....
Published:
Last Updated:
If the brand of Lance Armstrong was a stock, let’s just be nice say that the value would have tanked. The reality is that the exchange would have probably halted trading if it was public. After the...
Published:
Last Updated:
The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold short from...
Published:
Last Updated:
With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short interest changes from September 14 settlement date versus the August 31 settlement date....
Published:
The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date versus the August 15 settlement date. We have tracked the key short...
Published:
While many individual Americans are struggling financially, some of the largest corporations in the United States are sitting on billions in cash. Moody’s pointed out in March that U.S....
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Wednesday. Amgen Inc. (NASDAQ: AMGN) cut to Neutral at R.W. Baird. Automatic Data...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Monday. Advanced Micro Devices Inc. (NYSE: AMD) raised to Neutral from Sell at...
Published:
Last Updated:
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date. We have tracked the key short...
Published:
It was just on Monday that we released the 24/7 Wall St. “12 Big Dividend Hikes Coming Before The End of 2012” and we already have one of the twelve coming true. Altria Group Inc. (NYSE: MO)...
Published:
Last Updated:
Most investors have discovered that earning less than 1% per year in short-term Treasuries or even less than 2% out in the 10-year Treasury is no fun. Longer-dated Treasury bonds also are proving...
Published:
Last Updated:
The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short sellers generally have retreated from their gambles on biotech firms. For the period...
Published:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday morning. Amgen Inc. (NASDAQ: AMGN) raised to Buy at Lazard. American Tower...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Thursday morning. Abercrombie & Fitch Co. (NYSE: ANF) cut to Neutral at Baird...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.